These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9289806)

  • 1. [New therapeutic possibilities in chronic inflammatory bowel diseases].
    Zeitz M
    Praxis (Bern 1994); 1997 Jun; 86(25-26):1071-4. PubMed ID: 9289806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Crohn disease and ulcerative colitis--newer therapeutic approaches].
    Ewe K
    Z Gastroenterol; 1993 Feb; 31(2):151-5. PubMed ID: 8096666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New therapeutic data in inflammatory colitis].
    Karsenti P
    Ann Gastroenterol Hepatol (Paris); 1996; 32(1):10. PubMed ID: 8669802
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J
    Praxis (Bern 1994); 1995 Jan; 84(2):29-33. PubMed ID: 7839043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: systemic and topical steroids in inflammatory bowel disease.
    Schölmerich J
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():66-74. PubMed ID: 15352897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
    Sutherland LR
    CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing therapy for inflammatory bowel disease.
    Robinson M
    Am J Gastroenterol; 1997 Dec; 92(12 Suppl):12S-17S. PubMed ID: 9395347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local or systemic treatment of inflammatory bowel diseases?].
    Schmassmann A; Halter F
    Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Standards, perspectives and limits of conservative therapy of chronic inflammatory bowel diseases].
    Rogler G; Andus T; Schölmerich J
    Zentralbl Chir; 1998; 123(4):316-24. PubMed ID: 9622888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of chronic inflammatory intestinal diseases].
    Raedler A; Reinecker C
    Immun Infekt; 1990 Aug; 18(4):121-6. PubMed ID: 2210794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of chronic inflammatory bowel diseases].
    Beglinger C
    Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
    Hibi T; Inoue N; Ogata H; Naganuma M
    J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Crohn disease: prevention and drug therapy].
    Gross V; Andus T; Schölmerich J
    Chirurg; 1995 Aug; 66(8):757-63. PubMed ID: 7587538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous cyclosporine in steroid refractory attacks of inflammatory bowel disease.
    Hermida-Rodriguez C; Cantero Perona J; Garcia-Valriberas R; Pajares Garcia JM; Mate-Jimenez J
    Hepatogastroenterology; 1999; 46(28):2265-8. PubMed ID: 10521978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic inflammatory bowel diseases and nutrition].
    Meier R
    Schweiz Med Wochenschr Suppl; 1996; 79():14S-24S. PubMed ID: 8701255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive therapy of inflammatory diseases of the large intestine].
    Rumiantsev VG; Rogozina VA; Osina VA
    Eksp Klin Gastroenterol; 2004; (6):89-98, 165. PubMed ID: 16259448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug treatment of chronic inflammatory bowel diseases: current status and prospects].
    Seibold F; Wagner AC; Göke B
    Schweiz Med Wochenschr; 2000 Feb; 130(7):222-32. PubMed ID: 10719713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.